Alcohol can increase the risk for prostate cancer, and drinking can negatively impact any current cancer treatments. Alcohol also can skew PSA test results.

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in England and Wales an option beyond docetaxel.

In this Avera Medical Minute, one patient explains how a team-based approach to his cancer care made all the difference.

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

In a world where cancer remains a formidable adversary, Mr Z's story serves as a poignant reminder of the importance of early intervention and the power of patient awareness. Don’t let the silence of ...

For Jose Espinoza, peace has always been found in the quiet moments, but in 2022, a persistent pain in his back began to ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

The evening before I sat down to speak to Andy Ryan he was watching Arsenal play Atletico Madrid at The Emirates Stadium with ...

The Nubeqa (darolutamide) regimen can be used to treat adult patients with advanced HSPC if docetaxel, a chemotherapy agent, ...

The Cancer Gene Therapy Market is poised for growth driven by rising cancer burdens, demand for precision therapies, and ...

Nearly 20% of new lung cancer cases now occur in people who have never smoked, with women representing the majority.